Manufacturing Engineer II jobs in United States
cer-icon
Apply on Employer Site
company-logo

CSL · 3 hours ago

Manufacturing Engineer II

positionSeqirus USA - NC - Holly Springs
timeFull-time
remoteOnsite
seniorityMid Level
date3+ years exp

CSL Seqirus is a leading provider of influenza vaccines, dedicated to protecting communities from seasonal influenza and global pandemic threats. The Manufacturing Engineer II will analyze production specifications, diagnose manufacturing equipment issues, and recommend improvements to enhance production methods and quality.

BiotechnologyHealth CareHealth DiagnosticsMedical
check
Comp. & Benefits

Responsibilities

Under guidance, analyze production specifications and plant capacity data
Diagnose and troubleshoot Manufacturing equipment in the Fill Finish space (Formulation, Filling, Inspection, Packaging)
Perform calculations to determine manufacturing processes, tools and manpower requirements
Recommend measures to improve production methods, equipment performance and quality of work

Qualification

GMP experienceManufacturing experienceBachelor's degreeTechnical education

Required

Bachelor's degree, or equivalent in related field, or equivalent vocational or technical education
3 years' manufacturing experience

Preferred

Experience of GMP on commercial or clinical production is strongly preferred

Benefits

Onsite Café
1/2 mile Walking Trail
Basketball and Tennis Courts
Access to Medical, Dental, Vision, Life Insurance
401K with a 6% match
Annual bonus
Accrued PTO
Wellness days
Floating holidays

Company

CSL

twittertwittertwitter
Glassdoor4.6
company-logo
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
dateFounded in 1916
location
Melbourne, Victoria, AUS
people-size10001+ employees
web-link
https://www.csl.com

Funding

Current Stage
Public Company
Total Funding
$111M
2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO

Leadership Team

leader-logo
Jeffrey Ball
Chief Sustainability Officer
linkedin
leader-logo
Joy Linton
Strategic Advisor
linkedin

Recent News

Pharma Letter
MHRA approves Kostaive mRNA COVID-19 vaccine
2026-01-03
MarketScreener
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
2025-12-07
thefly.com
CSL just upgraded at Canaccord, here's why
2025-10-29
Company data provided by crunchbase